Fortress Biotech
FBIO | NASDAQ
$1.71
-$0.17 (-9.04%)
At close: Nov 16, 2026, 4:00 PM ET
$1.71
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-9.04%
(1D)No price chart data available for 1D timeframe.
Rating
63.5
+1.0 ptsFundamentals Strong
Market Sentiment Neutral
Moat None
Sector Rank #106/1021 (Top 10%)
Key Statistics
Market Data
Market Cap $57.03M
1D Range
1.71 1.87
52W Range
1.71 4.38
Valuation (TTM)
PE 0.73
PB 0.36
EV/EBITDA -0.39
Valuation (NTM)
Forward PE 0.74
Forward PEG 0.00
Price Target $5.00
Cash Flow
FCF Yield 220.5%
SBC Adj. FCF Yield 216.2%
SBC Impact -2.0%
Margins
Gross Margin 63.2%
Operating Margin -42.5%
FCF Margin 179.7%
Growth (CAGR)
Revenue 3Y | 5Y -4.7% |
1.7%
Dil EPS 3Y | 5Y 546.7% |
78.2%
FCF 3Y | 5Y 801.5% |
92.2%
Returns
ROA 35.7%
ROE 74.7%
ROIC -13.1%
Financial Health
Net Cash
$124.1M
Current Ratio 2.93
Interest Coverage -3.28
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Fortress Biotech, Inc. operates as a biopharmaceutical firm dedicated to the development and commercialization of a diverse range of pharmaceutical and biotechnology products. The company currently of...
Sector Healthcare
Industry Biotechnology
Employees 78
IPO Date Nov 17, 2011
Website www.fortressbiotech.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 13, 2026
EPS
-$0.23
Beat +14.81%
YoY:
-309.09% REV
$19.16M
Miss -11.20%
YoY:
+8.67%Next Earnings
Apr 1, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$5.00
Upside
+192.40%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove FBIO